Commercialization and Entrepreneurship
As academic researchers, some of us may be interested in forming start-up companies to develop and market the drugs that are based on our research. Others may be happy to license our technology and findings to an existing company. Knowing how to evaluate potential drug markets and effectively pitch to investors will help both groups of academicians. With so much intellectual property generated in academia, a well-researched commercial assessment and an organized and effective pitch can make potential licensees or investors take notice. The goal is not to recapitulate the sophisticated marketing plans drawn up in industry, but to highlight the project’s potential and show some industry savvy. This chapter provides guidance on evaluating the commercial potential of the project, pitching to potential licensees, approaching venture capitalists, and funding the development of not-for-profit programs. The chapter also discusses legal and practical considerations, should the academic decide to form a start-up company.
KeywordsVenture Capital Visceral Leishmaniasis Initial Public Offering Business Entity Product Share
- 2.CDC press release recommending hepatitis C testing for US baby boomers. http://www.cdc.gov/nchhstp/newsroom/2012/HCV-Testing-Recs-PressRelease.html